The Proton Pump Inhibitors Market segment, based on drug type, is decisively led by Esomeprazole. This dominance is attributed to its high therapeutic efficacy and its strong market positioning since its launch, which continues to appeal to prescribers for initial and maintenance therapy for GERD and other acid-related conditions. Despite the competitive pressure from generics, its brand...